Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective study
An increase in hemoglobin levels is associated with an increase in MCV in patients treated with HIF-PHIs. The anti-anemic effects of ESA and HIF-PHIs may be influenced by baseline MCV values. However, long-term consequences need further evaluation.
Authors
- Shigeru Shibata (ORCID: https://orcid.org/0000-0002-6868-0626)
- Yoshihide Fujigaki (ORCID: https://orcid.org/0000-0003-2803-9161)
- Shigeyuki Arai
- Hitoshi Anzai
- Ryō Kido
- Kohei Odajima
- Maika Gojo
- Rena Matsui
- S. Taira
Institutions
- Shinshu University (JP)
- Teikyo University of Science (JP)
- Teikyo University (JP)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1186/s12882-024-03877-4
- Citations
- 2
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.91